TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29883188

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard analgesic care (Control)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Comparison of reflexology vs standard care
Number of subjects: 164
Study: 26519116

Group type: EXPERIMENTAL
Intervention: Bi-weekly rotation exercise classes (n=20)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Wait-list control group (n=15)
Number of subjects: 35
Study: 23548378

Group type: EXPERIMENTAL
Intervention: SMR conditioning training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham conditioning training
Number of subjects: 24
Study: 23377594

Group type: EXPERIMENTAL
Intervention: School-based intervention program
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (nonequivalent)
Number of subjects: 58
Study: 20199846

Group type: EXPERIMENTAL
Intervention: Goal-setting strategy (mental contrasting), cognitive behavioral therapy-oriented problem-solving approach, goal-pursuit strategy (implementation intentions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (routine treatment)
Number of subjects: 60
Study: 18018417

Group type: EXPERIMENTAL
Intervention: Switch therapy (injectable quinolone switched to oral quinolone)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Intravenous administration of carbapenem antibacterial agent
Number of subjects: 35
Study: 16287366

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (CM; 0.3 g.kg(‐1).day(‐1) + 20 g Polycose)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Lacto-ovo-vegetarian diet (LOV)
Number of subjects: 26
Study: 12403203

Group type: EXPERIMENTAL
Intervention: Static magnets
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo magnets
Number of subjects: 20
Study: 10444418

Group type: COMPARATOR
Intervention: Insulin infusion (0.25, 0.50, and 1 mU.kg(‐1).min(‐1)) in healthy controls
Number of subjects: 30

Group type: COMPARATOR
Intervention: Insulin deprivation or insulin replacement in type 1 diabetic subjects
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline in healthy controls
Number of subjects: 30
Study: 7816064

Group type: EXPERIMENTAL
Intervention: Methotrexate (25 mg once weekly)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 141
Study: 6760680

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 39
Study: 31149870

Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted multicomponent vaccine (CPS5/CPS8/α-toxin/ClfA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-adjuvanted multicomponent vaccine (CPS5/CPS8/α-toxin/ClfA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: α-toxin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ClfA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EbhA/IsaA/SdrE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-10
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MRPII, IsdA, and ClfA
Number of subjects: 0
Study: 30416089

Group type: EXPERIMENTAL
Intervention: Active ABM
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo ABM
Number of subjects: 123

Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 123
Study: 26813473

Group type: EXPERIMENTAL
Intervention: Conventional treatment plus trimetazidine hydrochloride for 6 months
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study: 24171895

Group type: EXPERIMENTAL
Intervention: Acupuncture with NSAIDs (zaltoprofen, 80 mg daily)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Acupuncture alone
Number of subjects: 45

Group type: COMPARATOR
Intervention: NSAIDs alone
Number of subjects: 45
Study: 22378036

Group type: EXPERIMENTAL
Intervention: Anti-TNF-α therapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (nontreatment)
Number of subjects: 55
Study: 19188654

Group type: EXPERIMENTAL
Intervention: Rx Medibottle
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral Syringe
Number of subjects: 0
Study: 17473087

Group type: EXPERIMENTAL
Intervention: Intervention centers (benchmarking and quality improvement practices)
Number of subjects: 4093

Group type: COMPARATOR
Intervention: Control centers (standard practices)
Number of subjects: 4093

Group type: EXPERIMENTAL
Intervention: Best-performing centers (not part of the trial)
Number of subjects: 4093
Study: 16879626

Group type: EXPERIMENTAL
Intervention: 8-mm tip catheter
Number of subjects: 82

Group type: COMPARATOR
Intervention: Cooled tip catheter
Number of subjects: 82
Study: 12492742

Group type: EXPERIMENTAL
Intervention: Combination of lanzoprazole 30 mg, clarithromycin OD 500 mg, and furazolidone 400 mg, once daily for 7 days (Group A)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Combination of lanzoprazole 30 mg, clarithromycin OD 500 mg, and furazolidone 200 mg, once daily for 7 days (Group B)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 79
Study: 10831005

Group type: EXPERIMENTAL
Intervention: Fexofenadine HCl 20 mg
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Fexofenadine HCl 60 mg
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Fexofenadine HCl 120 mg
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Fexofenadine HCl 240 mg
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study: 8842582

Group type: EXPERIMENTAL
Intervention: 23-day regimen of 20 micrograms ethinylestradiol plus 75 micrograms gestodene
Number of subjects: 60

Group type: COMPARATOR
Intervention: 21-day regimen of 20 micrograms ethinylestradiol plus 75 micrograms gestodene
Number of subjects: 60
Study: 1737667

Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6483118

Group type: EXPERIMENTAL
Intervention: Fentanyl (5.0 micrograms/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naloxone (3.0 micrograms/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isotonic saline (Control)
Number of subjects: 0
Study: 28436287

Group type: EXPERIMENTAL
Intervention: Positive affect (joy, hope)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Joy induction
Number of subjects: 220
Study: 28535726

Group type: EXPERIMENTAL
Intervention: Arousal reappraisal intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 27025124

Group type: EXPERIMENTAL
Intervention: RIPC applied during sevoflurane anesthesia
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: RIPC applied during propofol anesthesia
Number of subjects: 48

Group type: COMPARATOR
Intervention: CONTROL sev (sevoflurane anesthesia without RIPC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: CONTROL prop (propofol anesthesia without RIPC)
Number of subjects: 48
Study: 23428652

Group type: EXPERIMENTAL
Intervention: Multidisciplinary weekly family‐based behavioral group delivered via telemedicine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard physician visit intervention
Number of subjects: 58
Study: 20351375

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 32
Study: 18420096

Group type: EXPERIMENTAL
Intervention: CoStar drug-eluting stent (DES)
Number of subjects: 1675

Group type: COMPARATOR
Intervention: Taxus drug-eluting stent (DES)
Number of subjects: 1675
Study: 16273750

Group type: EXPERIMENTAL
Intervention: Right ventricular apex pacing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternative pacing sites and specific algorithms
Number of subjects: 0
Study: 13129448

Group type: EXPERIMENTAL
Intervention: Beta-cryptoxanthin esters from papaya (1.3 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Non-esterified beta-cryptoxanthin (1.3 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 12
Study: 10815894

Group type: EXPERIMENTAL
Intervention: Surgical removal of tumor
Number of subjects: 93

Group type: COMPARATOR
Intervention: Antivascular endothelial growth factor antibodies
Number of subjects: 93

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 93
Study: 9028752

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin 100 mg
Number of subjects: 78

Group type: COMPARATOR
Intervention: Intravenous pethidine alone
Number of subjects: 78
Study: 1667648

Group type: EXPERIMENTAL
Intervention: Dietary fibre supplementation (wheat fibre and ispaghula) at an average intake of 16 g per day for six months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (during the wash-out period)
Number of subjects: 10
Study: 6219156

Group type: EXPERIMENTAL
Intervention: Inhaled ipratropium plus oral oxtriphylline
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol plus oral oxtriphylline
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Inhaled ipratropium and fenoterol plus oral oxtriphylline
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31953533

Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 15

Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 15
Study: 30781529

Group type: EXPERIMENTAL
Intervention: BRINDA internal regression adjustment for CRP and AGP
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Other adjustment methods (arithmetic correction factors, exclusion of subjects with inflammation, higher ferritin cut-off)
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: No adjustment for inflammation
Number of subjects: 872
Study: 28955064

Group type: EXPERIMENTAL
Intervention: Diathermy incision
Number of subjects: 58

Group type: COMPARATOR
Intervention: Scalpel incision
Number of subjects: 58
Study: 26637166

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (2 mg) administered as 3 monthly loading doses, followed by injections every 2 months over 12 months
Number of subjects: 49
Study: 24388619

Group type: EXPERIMENTAL
Intervention: Chlorthalidone-based stepped-care therapy
Number of subjects: 2375

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2375
Study: 23017669

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (three cycles of OxMdG: oxaliplatin 85 mg/m², l‐folinic acid 175 mg, fluorouracil 400 mg/m² bolus, then 2400 mg/m² by 46 h infusion) followed by surgery and a further nine cycles of OxMdG
Number of subjects: 150

Group type: COMPARATOR
Intervention: Postoperative chemotherapy (12 cycles of OxMdG)
Number of subjects: 150
Study: 19203899

Group type: EXPERIMENTAL
Intervention: FOLFOX plus bevacizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FOLFOX plus cediranib (AZD2171)
Number of subjects: 0
Study: 17381504

Group type: EXPERIMENTAL
Intervention: High-fat diet enriched with MUFA (M)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional diet (C)
Number of subjects: 58
Study: 15288712

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (human regular insulin 4 x 40 IU/d)
Number of subjects: 38
Study: 10931114

Group type: EXPERIMENTAL
Intervention: rBet v 1 fragments (F1: aa1‐74 and F2: aa75‐160)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: rBet v 1 dimer
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: rBet v 1 trimer
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intraderal testing with rBet v 1 trimer
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intraderal testing with rBet v 1 fragments
Number of subjects: 36
Study: 9310280

Group type: EXPERIMENTAL
Intervention: Almokalant at 100 nmol/l
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Almokalant at 50 nmol/l
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Almokalant at 20 nmol/l
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Almokalant at 150 nmol/l
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Almokalant
Number of subjects: 82
Study: 8383057

Group type: EXPERIMENTAL
Intervention: ANP 0.5 micrograms kg‐1 bwt
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ANP 1.0 micrograms kg‐1 bwt
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ANP 1.5 micrograms kg‐1 bwt
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ANP 2.0 micrograms kg‐1 bwt
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 3510479

Group type: EXPERIMENTAL
Intervention: Chloramphenicol instilled after washing with normal saline (2 gm)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Normal saline washing without chloramphenicol
Number of subjects: 101
Study: 30803856

Group type: EXPERIMENTAL
Intervention: Low-power laser phototherapy (3 J/cm2, 808 nm, 100 mW)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo LPL phototherapy
Number of subjects: 30
Study: 28937221

Group type: EXPERIMENTAL
Intervention: Ibuprofen (800 mg tablet) under fasting conditions
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Ibuprofen (800 mg tablet) under fed conditions
Number of subjects: 23

Group type: COMPARATOR
Intervention: Ibuprofen (800 mg tablet)
Number of subjects: 23
Study: 25982133

Group type: COMPARATOR
Intervention: Subanaesthetic ketamine (0.29 mg kg(‐1) h(‐1) for 1 h, followed by 0.57 mg kg(‐1) h(‐1) for another hour)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 23813743

Group type: EXPERIMENTAL
Intervention: 5 mg 4-aminopyridine (4-AP) four times a day for 3 days
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 10 mg 4-aminopyridine (4-AP) four times a day for 4 days
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP)
Number of subjects: 27

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study: 21541781

Group type: EXPERIMENTAL
Intervention: Macitentan 600 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Macitentan 300 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Macitentan
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: ACT-132577
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 18696107

Group type: EXPERIMENTAL
Intervention: High similarity between targets and distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targets following one another directly (lag-1 condition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Over-committing resources to target processing
Number of subjects: 0
Study: 17400413

Group type: EXPERIMENTAL
Intervention: computer-based hormone therapy decision-aid
Number of subjects: 177

Group type: COMPARATOR
Intervention: printed pamphlet (control)
Number of subjects: 177
Study: 15121737

Group type: EXPERIMENTAL
Intervention: CT measurements at L4‐L5
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: MRI measurements at L4‐L5
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: CT measurements
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: MRI measurements
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: CT and MRI measurements
Number of subjects: 200
Study: 11590704

Group type: EXPERIMENTAL
Intervention: Mediterranean-type diet
Number of subjects: 42

Group type: COMPARATOR
Intervention: High-fat diet
Number of subjects: 42
Study: 10419902

Group type: EXPERIMENTAL
Intervention: MDR1/P-glycoprotein expression
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Functional drug efflux (assessed using Di(OC)(2) and Rhodamine 123)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: MRP1 expression
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: LRP expression
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Cyclopsorine-resistant efflux
Number of subjects: 352
Study: 7587453

Group type: EXPERIMENTAL
Intervention: Exercise training consisting of 1 h of group walking twice daily, with intensity stratified into four levels based on initial exercise capacity.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 42
Study: 2276014

Group type: EXPERIMENTAL
Intervention: Adjuvant postoperative combination chemotherapy (5‐fluorouracil, lomustine (CCNU) and vincristine)
Number of subjects: 334

Group type: COMPARATOR
Intervention: No adjuvant therapy (Control)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Adjuvant postoperative combination chemotherapy
Number of subjects: 334
Study: 6157615

Group type: EXPERIMENTAL
Intervention: CVPP scheme (modified MOPP scheme)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Synchronization therapy (control group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: CVPP scheme (for advanced non-Hodgkin lymphomas)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Synchronization therapy (for advanced non-Hodgkin lymphomas)
Number of subjects: 72
Study: 31641913

Group type: EXPERIMENTAL
Intervention: QL2 regional anesthesia with 150 mg of ropivacaine combined with standard analgesia
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham intervention with standard analgesia
Number of subjects: 62
Study: 31469923

Group type: EXPERIMENTAL
Intervention: Injectable poly-L-lactic acid (PLLA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Injectable poly-D,L-lactic acid (PDLLA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyaluronic acid
Number of subjects: 0
Study: 27403887

Group type: EXPERIMENTAL
Intervention: EMLA® cream (anaesthetic cream), n = 34, applied on the volar part of the forearm, treatment repeated at increasing intervals over 8 weeks.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo cream, n = 36, applied on the volar part of the forearm, treatment repeated at increasing intervals over 8 weeks.
Number of subjects: 70
Study: 25271011

Group type: EXPERIMENTAL
Intervention: Vitamin D 3 (250,000 IU, single dose in November)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 23672272

Group type: EXPERIMENTAL
Intervention: Comprehensive school-based intervention including motivational counseling, Internet-based feedback, and after-school physical activity club
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group (not receiving the intervention)
Number of subjects: 1200
Study: 21177840

Group type: EXPERIMENTAL
Intervention: Higher indoor NO(2) levels (per logged unit increase)
Number of subjects: 409
Study: 19013548

Group type: EXPERIMENTAL
Intervention: Complete anterior cutout seat
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard seat
Number of subjects: 30

Group type: COMPARATOR
Intervention: Partial cutout seat
Number of subjects: 30
Study: 17202008

Group type: EXPERIMENTAL
Intervention: Lidocaine (2 mL, 40 mg, 2%)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Diphenhydramine (2 mL, 20 mg)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (2 mL normal saline)
Number of subjects: 180
Study: 12972673

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (60%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-fat diet (55%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Weight loss regimen
Number of subjects: 8
Study: 10973445

Group type: EXPERIMENTAL
Intervention: HIV type 1 (HIV-1) immunogen (Remune)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Adjuvant control
Number of subjects: 297
Study: 8793044

Group type: EXPERIMENTAL
Intervention: High chemical odor intolerance group (n = 15)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dairy-containing diet
Number of subjects: 15

Group type: COMPARATOR
Intervention: Low chemical odor intolerance group (n = 15)
Number of subjects: 15
Study: 1480917

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg nightly (increased to 40 mg if cholesterol > 200 mg/dl after 6 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Gemfibrozil 600 mg twice daily (dose kept constant)
Number of subjects: 31
Study: 6500445

Group type: EXPERIMENTAL
Intervention: Split tetanus vaccine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Normal adsorbed toxoid vaccine
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 2944434

Group type: EXPERIMENTAL
Intervention: Ketanserin by continuous infusion
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (equal infusion rate)
Number of subjects: 19
Study: 29741630

Group type: EXPERIMENTAL
Intervention: Machine Learning algorithms based on parent-reported questionnaires and home videos
Number of subjects: 162
Study: 27020698

Group type: EXPERIMENTAL
Intervention: Gel of chamomile
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cream of urea
Number of subjects: 48
Study: 23978956

Group type: COMPARATOR
Intervention: manikin+teacher instruction (control group)
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: manikin+video instruction
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: foam dice+plastic bag+peer training+teacher instruction
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: foam dice+plastic bag+peer training+video instruction
Number of subjects: 593
Study: 23201763

Group type: EXPERIMENTAL
Intervention: Beta-alanine (4 weeks loading phase of 4.8 g/day and 3.2 g/day thereafter)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 20522841

Group type: EXPERIMENTAL
Intervention: Indacaterol 300 microg and 600 microg
Number of subjects: 1732

Group type: COMPARATOR
Intervention: Formoterol 12 microg
Number of subjects: 1732

Group type: EXPERIMENTAL
Intervention: Indacaterol (both doses)
Number of subjects: 1732

Group type: EXPERIMENTAL
Intervention: Indacaterol
Number of subjects: 1732

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1732
Study: 18272750

Group type: EXPERIMENTAL
Intervention: Therapeutic touch
Number of subjects: 51

Group type: COMPARATOR
Intervention: Simulated therapeutic touch
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 51
Study: 15998756

Group type: EXPERIMENTAL
Intervention: Dietary protein intake; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lifestyle interventions (controlling body weight, reducing dietary salt, increasing physical activity, maintaining moderate alcohol use); specific details not mentioned.
Number of subjects: 0
Study: 12757058

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (50 mg initially, increased to 100 mg or decreased to 25 mg depending on efficacy and/or tolerability)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate
Number of subjects: 125